Completed OBSERVATIONAL NCT03316404

Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response (EMPOWER)

Sponsor: DxTerity Diagnostics

Updated 9 times since 2017 Last updated: Aug 5, 2024 Started: Nov 7, 2017 Primary completion: Feb 24, 2020 Completion: Feb 25, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates MS and Multiple Sclerosis and is currently completed. DxTerity Diagnostics leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed

Status: Unknown → Completed
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jul 2020 — Jan 2021 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Jul 2018 — Jul 2020 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting

▶ Show 4 earlier versions

Jun 2018 — Jul 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Dec 2017 — Apr 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Nov 2017 — Dec 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DxTerity Diagnostics

Data source: DxTerity Diagnostics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Compton, United States